It would be interesting to investigate whether the expression levels of hepatic Adgrf1 mRNA in these ‘lean NAFLD’ patients are higher than in lean healthy controls. The gene discussed is ADGRF1; the disease is metabolic dysfunction-associated steatotic liver disease.